Description
Recombinant Adeno-associated Virus-Like Particles (AAV VLPs) are produced in insect cells with capsid protein VP1, VP2 and VP3. VLP is mimicking the native 3D structure of viruses which can elicit strong immune responses. However, VLPs lack viral genomic material which makes them non-infectious, unable to replicate and enhance the safety during manufacture and administration. AAV VLPs can be used in the development of AAV diagnostics and in vaccine development and R&D (including use as an immunogen).